13D/13G Filings - OnKure Therapeutics Inc. (OKUR)

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto 0, 1, Next
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2025-01-21
6:38 pm
Sale
2025-01-1613DReneo Pharmaceuticals, Inc.
RPHM
RiverVest Venture Fund III, L.P.196,198
1.550%
-57,224decrease
(-22.58%)
Filing
History
2024-11-14
4:00 pm
Purchase
2024-10-0413GOnKure Therapeutics, Inc.
OKUR
TANG CAPITAL MANAGEMENT, LLC294,626
2.300%
294,626increase
(New Position)
Filing
History
2024-11-14
10:11 am
Purchase
2024-09-3013GReneo Pharmaceuticals, Inc.
RPHM
HIGHBRIDGE CAPITAL MANAGEMENT LLC3,062,690
9.200%
3,062,690increase
(New Position)
Filing
History
2024-10-28
4:03 pm
Purchase
2024-10-0413GOnKure Therapeutics, Inc.
OKUR
Octagon Capital Advisors LP225,000
1.800%
225,000increase
(New Position)
Filing
History
2024-10-23
4:15 pm
Sale
2024-10-2213GOnKure Therapeutics, Inc.
OKUR
Deep Track Capital, LP660,136
5.220%
-24,020decrease
(-3.51%)
Filing
History
2024-10-16
4:30 pm
Sale
2024-10-0413GOnKure Therapeutics, Inc.
OKUR
Cormorant Asset Management LP1,837,739
14.520%
-57,978decrease
(-3.06%)
Filing
History
2024-10-11
5:24 pm
Purchase
2024-10-0413GOnKure Therapeutics, Inc.
OKUR
CITADEL ADVISORS LLC1,271,371
9.900%
1,271,371increase
(New Position)
Filing
History
2024-10-11
4:22 pm
Purchase
2024-10-0413GOnKure Therapeutics, Inc.
OKUR
Cormorant Asset Management LP1,895,717
14.980%
1,895,717increase
(New Position)
Filing
History
2024-10-11
4:15 pm
Purchase
2024-10-0413GOnKure Therapeutics, Inc.
OKUR
Samsara BioCapital, L.P. 824,155
6.500%
824,155increase
(New Position)
Filing
History
2024-10-11
4:00 pm
Purchase
2024-10-0413GOnKure Therapeutics, Inc.
OKUR
Deep Track Capital, LP684,156
5.410%
684,156increase
(New Position)
Filing
History
2024-10-10
6:57 pm
Purchase
2024-10-0413GOnKure Therapeutics, Inc.
OKUR
Perceptive Advisors LLC1,004,439
7.900%
1,004,439increase
(New Position)
Filing
History
2024-10-10
4:30 pm
Purchase
2024-10-0813DOnKure Therapeutics, Inc.
OKUR
Carlyle Group Inc.
CG
273,045
2.200%
273,045increase
(New Position)
Filing
History
2024-10-09
4:01 pm
Purchase
2024-10-0413GOnKure Therapeutics, Inc.
OKUR
ACORN BIOVENTURES, L.P.1,439,674
11.400%
1,439,674increase
(New Position)
Filing
History
2024-10-09
11:40 am
Purchase
2024-10-0913GOnKure Therapeutics, Inc.
OKUR
BML Investment Partners, L.P.447,815
3.500%
447,815increase
(New Position)
Filing
History
2024-10-08
7:34 pm
Sale
2024-10-0413DReneo Pharmaceuticals, Inc.
RPHM
New Enterprise Associates 15 L.P.0
0.000%
-478,549decrease
(Position Closed)
Filing
History
2024-09-26
4:00 pm
Sale
2023-12-2613GReneo Pharmaceuticals, Inc.
RPHM
TANG CAPITAL PARTNERS LP294,626
8.800%
-38,374decrease
(-11.52%)
Filing
History
2024-05-21
10:12 am
Purchase
2024-05-2113GReneo Pharmaceuticals, Inc.
RPHM
BML Investment Partners, L.P.369,296
11.000%
199,873increase
(+117.97%)
Filing
History
2024-05-08
4:33 pm
Unchanged
2024-05-0713DReneo Pharmaceuticals, Inc.
RPHM
New Enterprise Associates 15 L.P.478,549
14.300%
0
(Unchanged)
Filing
History
2024-02-05
4:01 pm
Purchase
2023-12-3113GReneo Pharmaceuticals, Inc.
RPHM
Octagon Capital Advisors LP225,000
6.750%
225,000increase
(New Position)
Filing
History
2024-01-16
5:54 pm
Purchase
2024-01-1013GReneo Pharmaceuticals, Inc.
RPHM
BML Investment Partners, L.P.169,423
5.100%
169,423increase
(New Position)
Filing
History
Goto 0, 1, Next